Thiobutabarbital

Thiobutabarbital

Clinical data
Other names	Thiobutabarbital, Inactin, Brevinarcon, 5-sec-Butyl-5-ethyl-2-thiobarbituric acid
ATC code	none
Identifiers
IUPAC name 5-sec-butyl-5-ethyl-2-thioxodihydropyrimidine-4,6(1H,5H)-dione
CAS Number	2095-57-0 N
PubChem CID	3032373
ChemSpider	2297366 Y
UNII	2N0251U7JH
ECHA InfoCard	100.016.600
Chemical and physical data
Formula	C10H16N2O2S
Molar mass	228.31 g·mol−1
3D model (JSmol)	Interactive image
SMILES O=C1NC(=S)NC(=O)C1(C(C)CC)CC
InChI InChI=1S/C10H16N2O2S/c1-4-6(3)10(5-2)7(13)11-9(15)12-8(10)14/h6H,4-5H2,1-3H3,(H2,11,12,13,14,15) Y Key:IDELNEDBPWKHGK-UHFFFAOYSA-N Y
NY (what is this?)  (verify)

Thiobutabarbital (Inactin, Brevinarcon) is a short-acting barbiturate derivative invented in the 1950s. It has sedative, anticonvulsant and hypnotic effects, and is still used in veterinary medicine for induction in surgical anaesthesia.^[1]

Stereochemistry

Thiobutabarbital contains a stereocenter and consists of two enantiomers. This is a racemate, i.e. a 1: 1 mixture of ( R ) - and the ( S ) - form:^[2]

Enantiomers of Thiobutabarbital
(R)-Form	(S)-Form

References

This sedative-related article is a stub. You can help Wikipedia by expanding it.

• v
• t
• e

This page was last edited on 19 December 2023, at 16:40